Delonix Bioworks is a Shanghai-based startup using synthetic biology to design bacteria to act as safer and more effective vaccines against bacterial infections and cancer.
The Delonix team has developed a novel approach that builds on the established concept of live attenuated bacteria and combines it with the latest developments in synthetic biology. Delonix’s synthetic biology and antigen discovery platforms enable rational design and programming of bacteria into vaccines that are expected to be safer and more effective.
Initial lead programs will target anti-microbial resistance (AMR), including resistant bacteria such as methicillin-resistant Staphylococcus aureus (MRSA). The company says that antimicrobial resistance is projected to cause up to 10 million deaths annually by 2050.
The company recently raised $14m in seed funding to accelerate the building of its platforms and advance its pipelines of synthetic vaccines to clinical trials.
Subscribe for alerts on new companies featured on Startups.Bio
BioTryp Therapeutics is University of Cambridge spin-out biotechnology company that focuses on the development of small molecules to inhibit biofilm formation, which causes 80% of …
Bastion Therapeutics is a pre-clinical stage biotechnology company focused on developing best-in-class Treg cell therapies, which can target the root causes of inflammatory disorders and …
HOVANA is a digital biology company tackling translational dysfunction as a driver of serious diseases. Leveraging insights into cellular reprogramming, HOVANA is inventing a new …
Founded in 2022, Couragene is a biotechnology company developing first-in-class in vivo genetic therapies using its proprietary delivery platforms. The company's technology holds potential for …
Function Oncology is a precision medicine company advancing a CRISPR-powered personalized functional genomics platform to understand cancer in unprecedented and patient-specific detail. By moving beyond …
Founded in 2023, Mallia Therapeutics is a biopharmaceutical company developing soluble CD83 (sCD83) for the treatment of hair loss. sCD83, which was discovered as an …